Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M43,792Revenue $M5,770Net Margin (%)-9.4Z-Score1.4
Enterprise Value $M60,695EPS $-2.7Operating Margin %1.2F-Score3
P/E(ttm))0Cash Flow Per Share $4.9Pre-tax Margin (%)-14.0Higher ROA y-yN
Price/Book8.610-y EBITDA Growth Rate %3.6Quick Ratio1.7Cash flow > EarningsY
Price/Sales6.05-y EBITDA Growth Rate %38.0Current Ratio2.1Lower Leverage y-yN
Price/Cash Flow11.8y-y EBITDA Growth Rate %49.8ROA % (ttm)-2.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-13.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M335ROI % (ttm)-4.0Gross Margin Increase y-yN

Gurus Latest Trades with VRX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXGlenn Greenberg 2014-06-30 Add2.33%$116.99 - $138.13
($127.6)
$ 129.82%Add 8.19%6,050,442
VRXSteve Mandel 2014-06-30 Add0.64%$116.99 - $138.13
($127.6)
$ 129.82%Add 14.44%10,089,450
VRXLee Ainslie 2014-06-30 Add0.37%$116.99 - $138.13
($127.6)
$ 129.82%Add 8.39%2,625,014
VRXGeorge Soros 2014-06-30 Add0.29%$116.99 - $138.13
($127.6)
$ 129.82%Add 185.46%472,187
VRXJoel Greenblatt 2014-06-30 Buy 0.01%$116.99 - $138.13
($127.6)
$ 129.82%New holding, 6172 sh.6,172
VRXDaniel Loeb 2014-06-30 Sold Out -0.48%$116.99 - $138.13
($127.6)
$ 129.82%Sold Out0
VRXJohn Paulson 2014-06-30 Reduce-0.32%$116.99 - $138.13
($127.6)
$ 129.82%Reduce -49.97%500,300
VRXWallace Weitz 2014-06-30 Reduce-0.19%$116.99 - $138.13
($127.6)
$ 129.82%Reduce -2.91%1,551,076
VRXMariko Gordon 2014-06-30 Sold Out -0.13%$116.99 - $138.13
($127.6)
$ 129.82%Sold Out0
VRXLee Ainslie 2014-03-31 Add1.46%$112.62 - $148
($136.19)
$ 129.8-5%Add 48.23%2,421,778
VRXJohn Paulson 2014-03-31 Buy 0.65%$112.62 - $148
($136.19)
$ 129.8-5%New holding, 1000000 sh.1,000,000
VRXSteve Mandel 2014-03-31 Add0.61%$112.62 - $148
($136.19)
$ 129.8-5%Add 13.67%8,816,702
VRXDaniel Loeb 2014-03-31 Buy 0.48%$112.62 - $148
($136.19)
$ 129.8-5%New holding, 250000 sh.250,000
VRXGeorge Soros 2014-03-31 Buy 0.22%$112.62 - $148
($136.19)
$ 129.8-5%New holding, 165411 sh.165,411
VRXGlenn Greenberg 2014-03-31 Reduce-2.5%$112.62 - $148
($136.19)
$ 129.8-5%Reduce -8.52%5,592,558
VRXWallace Weitz 2014-03-31 Reduce-0.99%$112.62 - $148
($136.19)
$ 129.8-5%Reduce -13.61%1,597,540
VRXLou Simpson 2014-03-31 Reduce-0.25%$112.62 - $148
($136.19)
$ 129.8-5%Reduce -2.65%1,614,593
VRXMariko Gordon 2014-03-31 Reduce-0.1%$112.62 - $148
($136.19)
$ 129.8-5%Reduce -45.69%24,276
VRXLee Ainslie 2013-12-31 Buy 2.5%$103.04 - $117.42
($109.47)
$ 129.819%New holding, 1633838 sh.1,633,838
VRXJulian Robertson 2013-12-31 Sold Out -2.5%$103.04 - $117.42
($109.47)
$ 129.819%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRX Joel Greenblatt 2014-06-306,17200.01New Buy
VRX George Soros 2014-06-30472,1870.140.45+185.46%
VRX Steve Mandel 2014-06-3010,089,4503.015.1+14.44%
VRX Jean-Marie Eveillard 2014-06-301,024,4020.310.31+13.5%
VRX Lee Ainslie 2014-06-302,625,0140.784.8+8.39%
VRX Glenn Greenberg 2014-06-306,050,4421.830.8+8.19%
VRX Ruane Cunniff 2014-06-3034,298,38410.2323.1+0.24%
VRX Lou Simpson 2014-06-301,615,5490.488.2+0.06%
VRX Jeff Ubben 2014-06-3018,923,8775.6417.6
VRX Wallace Weitz 2014-06-301,551,0760.465.9-2.91%
VRX John Paulson 2014-06-30500,3000.150.27-49.97%
VRX Mariko Gordon 2014-06-30000Sold Out
VRX Daniel Loeb 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-06-23Sell10,203$121.77.81view
Mirovsky PavelPresident of Valeant Europe 2014-06-02Sell10,000$131.25-0.04view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-05-13Sell10,000$130.080.86view
Provencio Norma AnnDirector 2014-04-01Sell5,000$132.18-0.74view
Kornwasser LaizerEVP, Company Group Chairman 2014-03-21Buy2,481$134.97-2.79view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-03-17Sell5,000$141.72-7.42view
Provencio Norma AnnDirector 2014-03-03Sell5,000$141.62-7.36view
Provencio Norma AnnDirector 2014-02-03Sell5,000$136.23-3.69view
Kornwasser LaizerEVP, Company Group Chairman 2014-01-24Buy2,536$132.15-0.72view
Provencio Norma AnnDirector 2014-01-13Sell5,000$133-1.35view

Press Releases about VRX :

    Quarterly/Annual Reports about VRX:

    News about VRX:

    Articles On GuruFocus.com
    Most Held Canadian Stocks of the Second Quarter Sep 04 2014 
    Valeant Pharmaceuticals Part XII: the rolling solvency calculation Sep 02 2014 
    Valeant Pharmaceuticals part XI: Less luscious lips Aug 13 2014 
    Valeant Pharmaceuticals Part X: a follow up on the sale of facial injectables Aug 11 2014 
    Diamond Hill Capital Comments on Valeant Pharmaceuticals International Inc Jul 25 2014 
    Ackman Explains Valeant Bid, Makes Up with Carl Icahn Jun 09 2014 
    The Top Guru-Held Canadian Stocks of the First Quarter May 28 2014 
    Jim Chanos on Green Mountain Short, China Short, Valeant and Short Selling May 15 2014 
    Bill Ackman Interview: Forgiving Icahn, Valeant Merger, Fannie Mae and Freddie Mac May 05 2014 
    Mario Gabelli on Bill Ackman, Valeant, AT&T, DirecTV and Pfizer May 02 2014 

    More From Our Partners
    Deal Frenzy: 2014 Sees Record M&A Volume Sep 29 2014 - FOXBUSINESS

    More From Other Websites
    Ackman Fund Raises More Than $3 Billion in Amsterdam I.P.O. Oct 01 2014
    11:36 am Valeant Pharma's Bridgewater location receives warning letter from FDA Sep 30 2014
    Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA Sep 30 2014
    Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA Sep 30 2014
    Valeant's Bausch + Lomb Announces Results on Lotemax Sep 30 2014
    Large-Cap Tech Names Hang Tough In Shaky Market Sep 29 2014
    Rebound Efforts Fade For Stocks; Synchronoss Clears Resistance Sep 29 2014
    Today's Stocks Driving Success For The Drugs Industry Sep 29 2014
    Where the Allergan-Valeant(-Salix-Actavis-Teva) Fights Stand Now Sep 29 2014
    3 Likely Biotech Buyout Candidates Sep 29 2014
    Drugs groups trapped in tangled M&A web Sep 28 2014
    Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix Sep 28 2014
    Major Allergan Investor Joins Chorus Against Salix Deal Sep 27 2014
    Why Allergan (AGN) Stock Is Declining in After-Hours Trading Today Sep 26 2014
    T. Rowe joins concerns over Allergan governance Sep 26 2014
    Allergan Writes Back, Coaxes Shareholders Against Valeant Sep 26 2014
    T. Rowe Price urges Allergan to drop Salix bid Sep 26 2014
    T.Rowe Calls For Shareholder Vote On Allergan's Plans Too Sep 26 2014
    Pentwater Comes Out Swinging Against Allergan Board, Possible Salix Deal Sep 26 2014
    Meet 5 Top Stocks With Rising Earnings Estimates Sep 26 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK